| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ACELYRIN, Inc. | CFO and CBO | Common Stock | 40.8K | $302K | $7.41 | Oct 4, 2023 | Indirect |
| NEKTAR THERAPEUTICS | SVP, COO & CFO | Common Stock | 313K | $153K | $0.49 | May 16, 2022 | Direct |
| ACELYRIN, Inc. | CFO and CBO | Common Stock | 6.25K | $46.3K | $7.41 | Oct 4, 2023 | Direct |
| ACELYRIN, Inc. | CFO and CBO | Employee Stock Option (right to buy) | 184K | May 23, 2024 | Direct | ||
| ACELYRIN, Inc. | CFO and CBO | Employee Stock Option (right to buy) | 150K | Aug 31, 2024 | Direct | ||
| Rezolute, Inc. | Director | Director Stock Option (Right to Buy) | 30K | Jan 23, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SLRN | ACELYRIN, Inc. | Aug 31, 2024 | 1 | $0 | 4 | Sep 4, 2024 | CFO and CBO |
| SLRN | ACELYRIN, Inc. | May 23, 2024 | 1 | $0 | 4 | May 24, 2024 | CFO and CBO |
| RZLT | Rezolute, Inc. | Jan 23, 2024 | 1 | $0 | 4 | Jan 25, 2024 | Director |
| SLRN | ACELYRIN, Inc. | Jan 9, 2024 | 1 | $0 | 4 | Jan 11, 2024 | Chief Financial Officer |
| SLRN | ACELYRIN, Inc. | Oct 4, 2023 | 1 | $0 | 4 | Oct 6, 2023 | Chief Financial Officer |
| SLRN | ACELYRIN, Inc. | Aug 17, 2023 | 1 | $0 | 4 | Aug 21, 2023 | Chief Financial Officer |
| SLRN | ACELYRIN, Inc. | Aug 2, 2023 | 0 | $0 | 3 | Aug 3, 2023 | Interim CFO |
| RZLT | Rezolute, Inc. | Jun 23, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Director |
| NKTR | NEKTAR THERAPEUTICS | May 15, 2022 | 2 | -$68.9K | 4 | May 17, 2022 | SVP, COO & CFO |
| RZLT | Rezolute, Inc. | May 4, 2022 | 1 | $200K | 4/A | May 9, 2022 | Director |
| NKTR | NEKTAR THERAPEUTICS | Feb 16, 2022 | 1 | -$83K | 4 | Feb 18, 2022 | SVP, COO & CFO |
| NKTR | NEKTAR THERAPEUTICS | Dec 16, 2021 | 2 | $0 | 4 | Dec 20, 2021 | SVP, COO & CFO |
| NKTR | NEKTAR THERAPEUTICS | Nov 16, 2021 | 2 | -$316K | 4 | Nov 18, 2021 | SVP, COO & CFO |
| NKTR | NEKTAR THERAPEUTICS | Nov 15, 2021 | 0 | $0 | 4/A | Dec 20, 2021 | SVP, COO & CFO |
| NKTR | NEKTAR THERAPEUTICS | Oct 12, 2021 | 1 | $0 | 4 | Oct 14, 2021 | SVP, COO & CFO |
| NKTR | NEKTAR THERAPEUTICS | Aug 16, 2021 | 2 | -$149K | 4 | Aug 18, 2021 | SVP, COO & CFO |
| RZLT | Rezolute, Inc. | Jun 14, 2021 | 1 | $0 | 4 | Jul 14, 2021 | Director |
| NKTR | NEKTAR THERAPEUTICS | May 17, 2021 | 1 | -$145K | 4 | May 19, 2021 | SVP, COO & CFO |